Home Page | Search FDA Site |
FDA A-Z Index | Contact FDA
July 9, 1998
Written Cooperative Research and Development Agreements (CRADA) or Material Transfer Agreements (MTA) are primarily the basis for outside collaborations. The following general categories contrast these transactions in which FDA scientists may be involved:
|No Agreement Necessary||MTA Needed||CRADA Needed|
|Material or information desired is not confidential||The material and or information is proprietary||Exchange of material and/or information takes place over a period of time for a collaborative purpose:|
|easily obtained substance||information that cannot be obtained without a secrecy agreement||interchange of ideas, staff, etc.; the non-Federal collaborator may contribute money|
|generally known procedure||a substance that embodies a trade secret||may be the subject of FDA policy issues|
|the probability of an invention using these is most unlikely||no true collaboration anticipated; data only may be provided||confidential information is likely to be exchanged|
|potential for causing appearance of individual or organizational conflict(s) of interest|
|reasonable possibility of inventions leading to patents, licensing and royalties|
Next Section: Purpose of MTA
PDF documents may be read with a free copy of the Adobe Acrobat Reader.
Microsoft Word files can be viewed with that application or with a document viewer available free from the Microsoft Web Site.